Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Clinical trial NCT01744249 · COMPLETED
Trial details
- NCT number
- NCT01744249
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2023-12-31
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.